CNS Healthcare

CNS Healthcare CNS Healthcare provides new treatment options through clinical trials at no cost. Compensation is provided to clinical trial participants.

Real Research, Real Results. Since our inception in 1996, CNS Healthcare has had the privilege of assisting in the development of some of the most widely prescribed medicines in the world. We continue to lead the way in providing the clinical research necessary to identify medications for the FDA to review and, once approved, physicians to prescribe.The following are some of the medicines we have

helped bring to market through our clinical research; prescriptions of these medicines now improve the lives of millions of people worldwide.

Binge eating disorder is a real and treatable medical condition, not a lack of willpower. If you experience recurring ep...
08/31/2026

Binge eating disorder is a real and treatable medical condition, not a lack of willpower. If you experience recurring episodes of eating large amounts of food while feeling unable to stop, a clinical research study may be an option to consider. CNS Healthcare is currently enrolling for binge eating disorder research. Qualified participants may receive study-related care at no cost, and compensation may be available for time and travel. Learn more by making an appt at www.cnshealthcare.com

We’re excited to share that Rebecca “Beckie” Klipper has been named Site Director at CNS Healthcare!During her several y...
08/28/2026

We’re excited to share that Rebecca “Beckie” Klipper has been named Site Director at CNS Healthcare!

During her several years with CNS Healthcare, Beckie has gained valuable experience and developed a strong understanding of our organization, our patients, and our team. She has consistently demonstrated a commitment to professional growth and continued development, including her ongoing pursuit of her MSN/NP.

The Site Director plays an important leadership role in the success of a clinical research site, overseeing day-to-day operations, supporting and developing the site team, and helping ensure studies are conducted with a continued focus on quality, collaboration, and the patient experience.

Beckie’s experience, dedication, and commitment to the success of those around her make her a wonderful fit for this leadership role, and we’re excited to see her take this next step in her career with CNS Healthcare.

Please join us in congratulating Beckie on this well-deserved promotion! 🎉

Please join us in congratulating Vladimir Predestin on his 10-year anniversary with CNS Healthcare!For the past decade, ...
08/27/2026

Please join us in congratulating Vladimir Predestin on his 10-year anniversary with CNS Healthcare!

For the past decade, Vlad has been the steady hand behind the technology and systems that keep our teams connected and our organization running. From managing critical system and phone issues to cybersecurity, access, software updates, hurricane preparedness, and the countless day-to-day technology questions that come his way, Vlad is someone our team knows they can count on.

What truly sets Vlad apart is not just his technical expertise, but the way he supports people. He approaches every challenge with patience, kindness, professionalism, and an incredible sense of calm. No matter how complicated the problem, or how frustrated the person asking for help may be, Vlad is always willing to listen, troubleshoot, and find a solution, often with a smile.

His dedication to CNS Healthcare and the people who work here has made a lasting impact on our organization. We are incredibly fortunate to have had Vlad as part of our team for the past 10 years.

Vlad, thank you for everything you do and for the commitment, reliability, and positivity you bring to CNS Healthcare every day.

Congratulations on this incredible milestone!
Here’s to 10 years and many more! 🎉

The Jacksonville team is proud to celebrate 30 years of CNS Healthcare and the beginning of an exciting new chapter with...
08/25/2026

The Jacksonville team is proud to celebrate 30 years of CNS Healthcare and the beginning of an exciting new chapter with Alcanza Clinical Research!

We’re thrilled to show off our new T-shirts and celebrate the incredible team behind the work. As we look ahead, we remain committed to making a difference through clinical research and bringing new opportunities to the communities we serve.

Cheers to 30 years of dedication, teamwork, and progress—and to all that’s ahead for our Jacksonville team!

Team CNS Healthcare Orlando is celebrating 30 years of advancing clinical research, and an exciting new chapter with Alc...
08/19/2026

Team CNS Healthcare Orlando is celebrating 30 years of advancing clinical research, and an exciting new chapter with Alcanza Clinical Research! Together, we are building on a proud legacy while expanding access to innovative clinical trials for the communities we serve.

Here’s to honoring our past, celebrating our team, and shaping the future of research together!

ADHD can affect focus, organization, restlessness, and daily routines at any age. CNS Healthcare is currently enrolling ...
08/13/2026

ADHD can affect focus, organization, restlessness, and daily routines at any age. CNS Healthcare is currently enrolling research studies for children and adults with ADHD. By participating, you or your child may help researchers learn more about potential future treatment options.

Qualified participants may receive study-related care at no cost, and compensation may be available for time and travel. Eligibility criteria apply. Learn more by making an appt at https://cnshealthcare.com/

Continuing education and collaboration are essential to advancing high-quality clinical research.Dr. Valerie Arnold, Pri...
08/12/2026

Continuing education and collaboration are essential to advancing high-quality clinical research.

Dr. Valerie Arnold, Principal Investigator and Haley Edmonds, Recruitment and Operations Liaison from our site in Memphis, TN recently attended a Phase 2 bipolar disorder recruitment refresher meeting in Chicago, representing CNS Healthcare and connecting with colleagues around strategies and best practices for supporting study recruitment.

These opportunities allow our team to strengthen their knowledge, share insights, and return better equipped to connect eligible participants with research opportunities that may help advance future treatment options.

Thank you, Valerie and Haley, for representing CNS Healthcare and your continued commitment to excellence in clinical research.

30 YEARS. 113 FDA-APPROVED TREATMENTS. ONE EXTRAORDINARY RESEARCH LEGACY.CNS Healthcare recently marked its 113th FDA-ap...
07/29/2026

30 YEARS. 113 FDA-APPROVED TREATMENTS. ONE EXTRAORDINARY RESEARCH LEGACY.

CNS Healthcare recently marked its 113th FDA-approved treatment with the approval of SIMTRIYO® (centanafadine) from Otsuka for the treatment of ADHD in adults and children ages 6 and older.

This milestone is especially meaningful as we celebrate 30 years of clinical research. Since 1996, CNS Healthcare participants, investigators and research teams have contributed to clinical trials involving 113 treatments that went on to receive FDA approval.
These treatments have helped transform care for people living with depression, ADHD, migraine, diabetes, obesity, Alzheimer’s disease, fibromyalgia and many other conditions.

Behind every approval are research volunteers who chose to participate, team members committed to conducting high-quality research and a shared belief that better treatment options are possible.

Our 113th approval.
Our 30th year.
One remarkable legacy of advancing medicine through research.

Thank you to every participant, family member, investigator, sponsor and CNS Healthcare team member who helped make these achievements possible.

CNS Healthcare: Where research is the answer.



SIMTRIYO® is approved for adults and pediatric patients ages 6 and older who weigh at least 20 kg. Otsuka’s FDA approval announcement confirms the approval was announced July 24, 2026.

07/28/2026

Finding new and more effective ways to treat Alcohol Use Disorder (AUD) remains a critical priority. Congratulations to Altimmune on the positive topline results from the RECLAIM Phase 2 trial evaluating pemvidutide for Alcohol Use Disorder. The study met its primary endpoint, demonstrating a statistically significant reduction in heavy drinking days while also achieving important secondary endpoints recognized by the FDA. These encouraging findings represent another meaningful step forward in the development of potential new treatment options for people living with AUD.

At CNS Healthcare, we are committed to partnering to advance clinical research that explores new approaches to preventing, treating, and managing Alcohol Use Disorder, along with many other serious health conditions. Congratulations to the Altimmune and CNS Healthcare teams, and, most importantly, we wish to express our sincere gratitude to every study participant who volunteers to help advance the future of medicine.



07/24/2026

See what it's like to join a clinical trial at CNS Healthcare.

Address

120 East 8th St * PO Box 3301
Jacksonville, FL
32206

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 12pm

Alerts

Be the first to know and let us send you an email when CNS Healthcare posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to CNS Healthcare:

Shortcuts

Share